MIAMI, Sept. 05, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, announced today that the Company’s management will be participating in the 25th Annual H.C. […]

NEW YORK, NY / ACCESSWIRE / September 1, 2023 / 1847 Holdings LLC (“1847” or the “Company”) (NYSE American:EFSH), a unique holding company that combines the attractive attributes of owning private, lower-middle market businesses with the liquidity and transparency of a publicly traded company, today announced that its subsidiary, Wolo Manufacturing Corp. (“Wolo”), has expanded into India […]

NEW YORK, NY – (NewMediaWire) – September 01, 2023 – Hanryu Holdings, Inc. (NASDAQ: HRYU), is pleased to announce its CEO, Chang Hyuk Kang, recently conducted an interview with SmallCapsDaily discussing the Company’s recent achievements, strategic direction, and vision for the future in the dynamic landscape of K-Culture fandom and media convergence. In the interview, Kang […]

Association member’s latest speakers culminate ten years of innovation and feature WiSA HT technology for best-in-class wireless multichannel audio capabilities SAN JOSE, Calif., August 31, 2023–(BUSINESS WIRE)–WiSA Association, a subsidiary of WiSA Technologies, Inc. (NASDAQ: WISA), announced today that Association member Buchardt Audio’s Anniversary 10 (A10) Active Wireless Speakers have earned WiSA Home Theater (HT) Interoperability […]

VIRGINIA BEACH, VA / ACCESSWIRE / August 29, 2023 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) (“Inspire” or the “Company”), an owner and provider of pet health care services throughout the US, today announced the pricing of its initial public offering of 1,600,000 shares of common stock at a public offering price of $4.00 per share for […]

Full enrollment anticipated by first week of September OKYO on schedule to release top-line data before end of 2023 Phase 2 trial is designed as potential registration trial with pre-specified primary efficacy endpoints covering both a sign and symptom of DED LONDON and NEW YORK, Aug. 30, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: […]

Acquisition to be Funded without the Issuance of Any Common Stock or Dilutive Equity Egan-Jones Affirms BBB+ Rating on Company’s Senior Credit Facility NEW YORK, NY / ACCESSWIRE / August 30, 2023 / 1847 Holdings LLC(“1847” or the “Company”) (NYSE American:EFSH), a unique holding company that combines the attractive attributes of owning private, lower-middle market businesses […]

NEW YORK and LONDON, Aug. 29, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (DED) to address the significant unmet need in this multi-billion-dollar market, today announced that it received notification from the Listing Qualifications Department (the “Staff”) […]